Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,826,685,679
+$1,661,729,188 QoQ
Shares Held
46,998,433
+0.6% QoQ
Ownership
2.66%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#6
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. ABBV ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,826,685,679 | 46,998,433 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,164,956,491 | 46,737,581 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,197,504,129 | 44,629,980 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,363,360,208 | 40,439,493 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,272,285,512 | 39,178,351 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,014,892,176 | 38,253,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,600,654,593 | 37,144,933 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,141,083,166 | 36,161,045 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,291,653,759 | 36,681,750 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,827,776,311 | 37,494,653 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,736,599,805 | 37,017,486 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,397,041,058 | 36,207,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,709,209,336 | 34,952,938 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,425,754,996 | 34,045,021 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,454,742,979 | 33,752,509 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,540,391,539 | 33,830,501 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,607,271,359 | 30,081,427 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,655,839,889 | 28,720,251 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,861,465,288 | 28,518,946 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,994,535,059 | 27,760,592 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,068,871,055 | 27,244,949 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,947,111,863 | 27,232,599 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,858,968,049 | 26,681,923 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,289,170,956 | 26,135,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,843,154,562 | 28,958,592 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,963,683,345 | 25,773,505 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||